Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries.
Animals
Antigens, CD
/ metabolism
Aorta
/ drug effects
Cells, Cultured
Diet, Fat-Restricted
Diet, High-Fat
Disease Models, Animal
Enzyme Activation
Human Umbilical Vein Endothelial Cells
/ drug effects
Humans
Insulin
/ pharmacology
Insulin-Like Growth Factor I
/ pharmacology
Male
Mesenteric Arteries
/ drug effects
Mice, Inbred C57BL
Obesity
/ blood
Phosphorylation
Proto-Oncogene Proteins c-akt
/ metabolism
Receptor, IGF Type 1
/ genetics
Receptor, Insulin
/ metabolism
Receptors, Somatomedin
/ metabolism
Signal Transduction
/ drug effects
Vascular Resistance
/ drug effects
Vasodilation
/ drug effects
IGF-1 receptors
Obesity
hybrid receptors
Journal
Diabetes & vascular disease research
ISSN: 1752-8984
Titre abrégé: Diab Vasc Dis Res
Pays: England
ID NLM: 101234011
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
pubmed:
9
10
2018
medline:
14
8
2019
entrez:
9
10
2018
Statut:
ppublish
Résumé
Insulin and insulin-like growth factor-1 stimulate specific responses in arteries, which may be disrupted by diet-induced obesity. We examined (1) temporal effects of high-fat diet compared to low-fat diet in mice on insulin receptor, insulin-like growth factor-1 receptor, insulin receptor/insulin-like growth factor-1 receptor hybrid receptor expression and insulin/insulin-like growth factor-1-mediated Akt phosphorylation in aorta; and (2) effects of high-fat diet on insulin and insulin-like growth factor-1-mediated Akt phosphorylation and vascular tone in resistance arteries. Medium-term high-fat diet (5 weeks) decreased insulin-like growth factor-1 receptor expression and increased hybrid expression (~30%) only. After long-term (16 weeks) high-fat diet, insulin receptor expression was reduced by ~30%, insulin-like growth factor-1 receptor expression decreased a further ~40% and hybrid expression increased a further ~60%. Independent correlates of hybrid receptor expression were high-fat diet, duration of high-fat diet and plasma insulin-like growth factor-1 (all p < 0.05). In aorta, insulin was a more potent activator of Akt than insulin-like growth factor-1, whereas in resistance arteries, insulin-like growth factor-1 was more potent than insulin. High-fat diet blunted insulin-mediated vasorelaxation ( p < 0.01) but had no effect on insulin-like growth factor-1-mediated vasorelaxation in resistance arteries. Our findings support the possibility that hybrid receptor level is influenced by nutritional and metabolic cues. Moreover, vessel-dependent effects of insulin and insulin-like growth factor-1 on vascular tone and Akt activation may have implications in treating obesity-related vascular disease.
Identifiants
pubmed: 30295509
doi: 10.1177/1479164118802550
pmc: PMC6484231
doi:
Substances chimiques
Antigens, CD
0
IGF1 protein, human
0
IGF1R protein, human
0
Igf1r protein, mouse
0
Insulin
0
Receptors, Somatomedin
0
Insulin-Like Growth Factor I
67763-96-6
INSR protein, human
EC 2.7.10.1
Receptor, IGF Type 1
EC 2.7.10.1
Receptor, Insulin
EC 2.7.10.1
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
160-170Subventions
Organisme : British Heart Foundation
ID : FS/12/80/29821
Pays : United Kingdom
Références
Endocrinology. 2009 Oct;150(10):4575-82
pubmed: 19608653
Diabetes. 2008 Dec;57(12):3307-14
pubmed: 18835939
Biochem J. 1997 Oct 1;327 ( Pt 1):209-15
pubmed: 9355755
J Biol Chem. 2006 Sep 8;281(36):25869-74
pubmed: 16831875
J Clin Endocrinol Metab. 1994 Jul;79(1):230-2
pubmed: 8027233
Diabetes. 2011 Aug;60(8):2169-78
pubmed: 21677284
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Diabetes. 1998 Jan;47(1):87-92
pubmed: 9421379
Endocrinology. 2005 Nov;146(11):4690-6
pubmed: 16099860
J Clin Endocrinol Metab. 2000 Nov;85(11):4219-23
pubmed: 11095457
PLoS One. 2013 Nov 18;8(11):e79710
pubmed: 24260289
Curr Biol. 2009 Aug 11;19(15):R657-66
pubmed: 19674551
Sci Rep. 2015 Jan 21;5:7911
pubmed: 25604425
J Clin Invest. 1996 Dec 15;98(12):2887-93
pubmed: 8981937
Diabetes. 2012 Sep;61(9):2359-68
pubmed: 22733797
J Clin Invest. 1999 Aug;104(4):447-57
pubmed: 10449437
Curr Opin Struct Biol. 2007 Dec;17(6):699-705
pubmed: 17851071
Endocr Rev. 2009 Oct;30(6):586-623
pubmed: 19752219
Cell Metab. 2011 Sep 7;14(3):390-402
pubmed: 21907144
J Hypertens. 2005 Feb;23(2):351-8
pubmed: 15662223
Biochem J. 1993 Mar 1;290 ( Pt 2):419-26
pubmed: 8452530
Diabetes. 2013 Jun;62(6):2130-4
pubmed: 23349484
Trends Endocrinol Metab. 2016 Feb;27(2):96-104
pubmed: 26712712
Hypertension. 1999 Jul;34(1):89-95
pubmed: 10406829
Diabetes. 1999 Dec;48(12):2277-85
pubmed: 10580414
Biochem J. 1998 Aug 1;333 ( Pt 3):825-31
pubmed: 9677346